ATNM
Price
$1.15
Change
-$0.05 (-4.17%)
Updated
Feb 4, 02:22 PM (EDT)
Capitalization
37.44M
37 days until earnings call
Intraday BUY SELL Signals
PRLD
Price
$2.21
Change
-$0.08 (-3.49%)
Updated
Feb 4, 03:11 PM (EDT)
Capitalization
143.33M
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATNM vs PRLD

Header iconATNM vs PRLD Comparison
Open Charts ATNM vs PRLDBanner chart's image
Actinium Pharmaceuticals
Price$1.15
Change-$0.05 (-4.17%)
Volume$100
Capitalization37.44M
Prelude Therapeutics
Price$2.21
Change-$0.08 (-3.49%)
Volume$100
Capitalization143.33M
ATNM vs PRLD Comparison Chart in %
ATNM
Daily Signal:
Gain/Loss:
PRLD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ATNM vs. PRLD commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Hold and PRLD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (ATNM: $1.20 vs. PRLD: $2.29)
Brand notoriety: ATNM and PRLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 63% vs. PRLD: 151%
Market capitalization -- ATNM: $37.44M vs. PRLD: $143.33M
ATNM [@Biotechnology] is valued at $37.44M. PRLD’s [@Biotechnology] market capitalization is $143.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whilePRLD’s FA Score has 1 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • PRLD’s FA Score: 1 green, 4 red.
According to our system of comparison, PRLD is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 4 TA indicator(s) are bullish while PRLD’s TA Score has 5 bullish TA indicator(s).

  • ATNM’s TA Score: 4 bullish, 6 bearish.
  • PRLD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PRLD is a better buy in the short-term than ATNM.

Price Growth

ATNM (@Biotechnology) experienced а -6.98% price change this week, while PRLD (@Biotechnology) price change was +8.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

ATNM is expected to report earnings on Mar 13, 2026.

PRLD is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRLD($143M) has a higher market cap than ATNM($37.4M). ATNM YTD gains are higher at: -11.765 vs. PRLD (-21.034). ATNM has higher annual earnings (EBITDA): -36.52M vs. PRLD (-119.27M). PRLD (55M) and ATNM (53.4M) have equal amount of cash in the bank . ATNM has less debt than PRLD: ATNM (1.14M) vs PRLD (17.9M). PRLD has higher revenues than ATNM: PRLD (10.5M) vs ATNM (90K).
ATNMPRLDATNM / PRLD
Capitalization37.4M143M26%
EBITDA-36.52M-119.27M31%
Gain YTD-11.765-21.03456%
P/E RatioN/AN/A-
Revenue90K10.5M1%
Total Cash53.4M55M97%
Total Debt1.14M17.9M6%
FUNDAMENTALS RATINGS
ATNM: Fundamental Ratings
ATNM
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATNMPRLD
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 6 days ago
80%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 6 days ago
74%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
71%
Bullish Trend 2 days ago
88%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATNM
Daily Signal:
Gain/Loss:
PRLD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GILT19.661.00
+5.36%
Gilat Satellite Networks Ltd
ROAD117.563.36
+2.94%
Construction Partners
KFFB4.49-0.02
-0.34%
Kentucky First Federal Bancorp
AMAT318.67-9.73
-2.96%
Applied Materials
LFCR7.97-0.55
-6.46%
Lifecore Biomedical

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with CRBU. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
-1.64%
CRBU - ATNM
44%
Loosely correlated
+6.85%
RXRX - ATNM
42%
Loosely correlated
-1.91%
CRSP - ATNM
40%
Loosely correlated
+1.34%
ACHV - ATNM
37%
Loosely correlated
-2.56%
HOWL - ATNM
36%
Loosely correlated
-2.42%
More

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with FDMT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then FDMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
+12.81%
FDMT - PRLD
40%
Loosely correlated
+3.72%
ATNM - PRLD
38%
Loosely correlated
-1.64%
FULC - PRLD
36%
Loosely correlated
-2.15%
IMNM - PRLD
36%
Loosely correlated
+3.18%
IPSC - PRLD
36%
Loosely correlated
N/A
More